RESPIRATORY PHARMACOLOGY - ASTHMA. Primary Exam Teaching - Westmead ED

Similar documents
Pharmacology of drugs used in bronchial asthma & COPD

Respiratory Pharmacology

Respiratory Pharmacology. Manuel Otero Lopez Department of Anaesthetics and Intensive Care Hôpital Européen Georges Pompidou, Paris, France

Clinical Indications. Clinical Indications. RSPT 2317 Methylxanthines. RSPT 2317 Methylxanthines

From the Text. Clinical Indications. Clinical Indications. Clinical Indications. Clinical Indications. RSPT 2317 Methylxanthines

Chapter 7. Anticholinergic (Parasympatholytic) Bronchodilators. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

Bronchial Asthma and COPD

Asthma Description. Asthma is a disease that affects the lungs defined as a chronic inflammatory disorder of the airways.

Pharmacology Drugs of Respiratory system. Drugs acting on respiratory system. Dr. Ahmad Al-Zohyri Lec. 11

기관지확장제와기관지천식 치료에쓰이는약물 이종호 한림의대약리학교실

Asthma- THE most common Pediatric Disease JENNIFER MCDANIEL, RRT- NPS

Chapter 55. Changes in the Airway With COPD. Manifestations of Severe COPD. Drugs Used to Treat Obstructive Pulmonary Disorders

Lecture Notes. Chapter 3: Asthma

On completion of this chapter you should be able to: discuss the stepwise approach to the pharmacological management of asthma in children

Impact of Asthma in the U.S. per Year. Asthma Epidemiology and Pathophysiology. Risk Factors for Asthma. Childhood Asthma Costs of Asthma

History & Development

Air Flow Limitation. In most serious respiratory disease, a key feature causing morbidity and functional disruption is air flow imitation.

Medications Affecting The Respiratory System

IPRAVENT Respules/Respirator solution (Ipratropium bromide)

RESPIRATORY PHARMACOLOGY

NEW ZEALAND DATA SHEET SEREVENT Accuhaler

Composition Each ml of Ventol solution for inhalation contains 5 mg Salbutamol (as sulphate).

Foundations of Pharmacology

VENTOLIN RESPIRATOR SOLUTION

COPD. Breathing Made Easier

Drugs acting on the respiratory tract

SEROBID Inhaler (Salmeterol xinafoate)

Integrated Cardiopulmonary Pharmacology Third Edition

Treatment. Assessing the outcome of interventions Traditionally, the effects of interventions have been assessed by measuring changes in the FEV 1

7.2 Part VI.2 Elements for a Public Summary

Platelet aggregation inhibitor. Cardiac chest pain or suspected Myocardial Infarction.

Respiratory Pharmacology PCTH 400 Asthma and β-agonists

Significance. Asthma Definition. Focus on Asthma

OXIS TURBUHALER 4.5 µg/dose and 9 µg/dose ASTRAZENECA

Recurrent wheezing illnesses 24.9% Similar to Australia Above global averages

ASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides

Robert Kruklitis, MD, PhD Chief, Pulmonary Medicine Lehigh Valley Health Network

Integrated Cardiopulmonary Pharmacology Third Edition

Exercise-Induced Bronchoconstriction EIB

NEW ZEALAND DATA SHEET

Systems Pharmacology Respiratory Pharmacology. Lecture series : General outline

Emily DiMango, MD Asthma II

Pharmacotherapy for Allergic Rhinitis

Asthma Management in ICU. by DrGary Au From KWH

Medicine Dr. Kawa Lecture 4 - Treatment of asthma :

Better Living with Obstructive Pulmonary Disease A Patient Guide

Systemic Pharmacology Lecture 7: Neuropharmacology

31 - Respiratory System

Asthma. chapter 7. Overview

Urticaria Moderate Allergic Reaction Mild signs/symptoms with any of following: Dyspnea, possibly with wheezes Angioneurotic edema Systemic, not local

VACCINE-RELATED ALLERGIC REACTIONS

IPRAVENT Rotacaps (Ipratropium bromide)

DRUG CLASSES BETA-ADRENOCEPTOR ANTAGONISTS (BETA-BLOCKERS)

Asthma/COPD. Asthma synopsis. chronic inflammation of bronchial airways bronchi lining bronchi muscles mucus

ASTHALIN Respirator Solution (Salbutamol sulphate)

Dr. Vishaal Bhat. anti-adrenergic drugs

Anaphylaxis. Perceive the differences between anaphylactic shock and other types of shock. Recognize its nature, causes & characteristics.

Pharmacokinetics Applied to the Treatment of Asthma

AEROCORT Inhaler (Beclomethasone dipropionate + Levosalbutamol)

Diagnosis, Assessment, Monitoring and Pharmacological Treatment of Asthma

New Zealand Datasheet

GenRx SALBUTAMOL INHALATION AMPOULE

ADULT ASTHMA GUIDE SUMMARY. This summary provides busy health professionals with key guidance for assessing and treating adult asthma.

Salapin: Salbutamol BP 2mg as sulphate in each 5mL of a raspberry cola flavoured, sugar free syrup.

Basic mechanisms disturbing lung function and gas exchange

PACKAGE INSERT TEMPLATE FOR SALBUTAMOL TABLET & SALBUTAMOL SYRUP

Autonomic Nervous System (ANS) وحدة اليوزبكي Department of Pharmacology- College of Medicine- University of Mosul

Atrovent Administration

Steven Berkowitz, DVM Chief, Emergency and Critical Care Saint Francis Veterinary Center

DUOLIN Rotacaps (Levosalbutamol sulphate + Ipratropium bromide)

ASTHMA ASTHMA DISEASE SUMMARY. Risk Factors

Drugs that Affect the Respiratory System BROOKE BENTLEY, PHD, APRN

Monocast Description Indications

number Done by Corrected by Doctor

WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS

ASTHALIN Respules (Salbutamol sulphate)

Composition: Each tablet contain. Levocetirizine. Each 5ml contains. Montelukast. Pharmacokinetic properties:

Asthma training. Mike Levin Division of Asthma and Allergy Red Cross Hospital

Chemical name: di[(rs)-2-(1,1-dimethyl)ethylamino-1-[4-hydroxy-3- (hydroxymethyl)phenyl]ethanol] sulphate

Pharmacology med term exam

Function of the Respiratory System. Exchange CO2 (on expiration) for O2 (on inspiration)

Lungs SLO Practice (online) Page 1 of 5

Clinical and experimental studies on theophylline toxicity: in search for and antidote

TIOVA Inhaler (Tiotropium bromide)

PRODUCT INFOMATION APO-IPRATROPIUM SOLUTION

Asthma Management for the Athlete

Utibron Neohaler. (indacaterol, glycopyrrolate) New Product Slideshow

PRODUCT INFORMATION VENTOLIN DISKS

PRODUCT INFORMATION TILADE CFC-FREE

NERVOUS SYSTEM NERVOUS SYSTEM. Somatic nervous system. Brain Spinal Cord Autonomic nervous system. Sympathetic nervous system

Chronic Obstructive Pulmonary Disease

Lujain Hamdan. Ayman Musleh & Yahya Salem. Mohammed khatatbeh

Asthma Pathophysiology and Treatment. John R. Holcomb, M.D.

Asthma - Chronic. Presentations of asthma Cough Wheeze Breathlessness Chest tightness

10/18/2012. Penn State University Children s Hospital JODIE STABINSKI CRNP MSN AE-C

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

COPD: A Renewed Focus. Disclosures

A Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children

BRICANYL INJECTION. terbutaline sulfate PRODUCT INFORMATION

500 micrograms/dose Turbohaler dry powder device 500 micrograms/ml injection. 12 micrograms/dose Turbohaler dry powder device

Transcription:

RESPIRATORY PHARMACOLOGY - ASTHMA Primary Exam Teaching - Westmead ED

Sympathomimetic agents MOA: relax airway smooth muscle and inhibit broncho constricting mediators from mast cells May also inhibit microvascular leakage and increase mucocilliary transport by increasing ciliary activity The beta agonists stimulate andeylyl cyclase and increase formation of intracellular camp Beta 2 effect causes Relaxation of airway smooth muscle Inhibits mediator release Causes tachycardia and skeletal muscle tremor as side effects Best mode of delivery is via inhalation - results in the greatest local effect on airway smooth muscle with the least systemic toxicity Aerosol deposition depends on particle size, pattern of breathing and geometry of airways - deposition can be increased by holding breath during inspiration

ADRENALINE Effective, rapidly acting bronchodilator Maximal bronchodilation 15 min after inhalation Stimulates alpha and beta one as well as beta two Causes tachycardia, arrythmias and worsening of angina pectoris These CV effects are of value for treating the acute vasodilation and shock as well as the bronchospasm of anaphylaxis

Beta 2 selective agents Salbutamol Use - asthma, hyperkalemia Pharmacokinetics A - 10-30% act directly on smooth muscle when inhaled, D - minimal entry into systemic circulation when inhaled, otherwise low Vd M - signifiant first pass metabolism E - excreted really Pharmacodynamics - selective beta two receptor agonist and causes bronchodilation Maximal effect within 15-30 minutes and persists for 3-4 hours Nebulisers are no more effective than MDI - should only be given when patients cannot coordinate their own breathing Longer acting agents such as salmeterol have a 12 hour duration as a result of HIGH LIPID SOLUBILITY - and appear to interact with corticosteroids to improve asthma control Adverse effects: Cardiac arrythmia and hypoxemia - ma increase the perfusion of poorly ventilated lung and thus transiently decrease arterial oxygenation - this is overcome by the administration of supplemental oxygen Fine tremor + palpitations + cramps

Methylxanthine drugs Three important agents Theophylline Theobromine Caffeine Importance as a therapeutic agent in asthma has weaned over time Aminophylline is a commonly used theophylline preparation Mechanism of action At high concentrations > inhibits phosphodiesterase enzyme family This results in higher concentrations of intracellular camp Another proposed mechanism in inhibition of cell surface adenosine receptors - which has been shown to provoke contraction of isolated airway smooth muscle and histamine release

Methylxanthine drugs Pharmacokinetics : A - 100% bioavailibilty, serum levels in 30-120 minutes D - low Vd 0.5L/kg, 60% protein bound M - hepatic E - 85-90% hepatic elimination, remainder renal, half life 4-8 hours Pharmacodynamics CNS effects - low and moderate doses, especially caffeine, can cause mild cortical arousal with increase alertness Larger doses are required for bronchodilation effects and in very high doses can cause convulsions and death CV effects - positive chronotropic and inotropic effects - at low doses these effects are thought to be mediated by inhibition of adenosine receptors in sympathetic nerves. Higher concentrations are associated with inhibition of phosphodiesterase and increased influx of calcium Results in slight tachycardia, increased CO, increased TPR, HTN GI - stimulates secretions

Methylxanthines Clinical use Theophylline is the most important bronchodilator Relieves airway obstruction in acute asthma and reduces severity of symptoms in chronic asthma Should only be used when methods to measure blood levels are available because it has a narrow therapeutic window Toxicity includes: Anorexia, Nausea, Vomiting, Higher levels cause seizures and arrhythmia Levels over 20mcg/mL Plasma clearance of theophylline varies wildly It is metabolised in the liver and should be used in caution in patients with liver disease

Antimuscarinic agents Mechanism of action - competitively inhibit the effect of acetylcholine at muscarinic receptors In the airways Ach is released from the parasympathetic nerve endings (muscarinic) and block airway smooth muscle relaxation and increase airway secretions Ipratropium Bromide Pharmacokinetics A: oral route - can be given in high doses because of its poor systemic absorption and lack of CNS penetration, onset of action 15 min D: low Vd and low systemic absorption M: hepatically E: Renal (46%) - half life 2 hours

Cromolyn and Nedocromil Mechanism of action: Mast cell stabiliser - inhibits release of histamine, leukotrienes and slow reacting substances of anaphylaxis by inhibiting mast cell degranulation Pharmacokinetics: A: PO bioavailibility 0.5-2% D: Peak plasma time 15 min M: E: 98% in feaces unabsorbed, half life 90 min Clinical use: Blocks bronchoconstriction caused by Allergen inhalation Exercise Sulfure dioxide Both agents reduce symptom severity and need for bronchodilator medications

Leukotrine pathway inhibitors Leukotirnes results from the activation of 5 - lipoxygenase on arachadonic acid and are synthesised by a variety of inflammatory mediators LTB 4 is a potent chemoattractant LTC4 and LTD4 are responsible for many of the effects associated with asthma Two pharmacological approaches exist to the inhibition of this pathway Inhibition of 5 - Lipoxygenase - preventing leukotrine synthesis Inhibition of binding of LTD4 to receptor of target tissues Have been shown to improve asthma control and reduce the frequency of exacerbations

Corticosteroids Presumed to act by broad anti-inflammatory mechanisms Reduce bronchial reactivity and reduce the frequency of asthma exacerbations if taken regularly Also induce contraction of engorged vessels in the bronchial mucosa and potentiate effects of beta receptor agonists Most important mechanism of action is the inhibition of lymphocytic, eosinophilic mucosal inflammation of asthmatic airways

Corticosteroids Effective in improving all indicies of asthma control Severity of symptoms Tests of airway calibre Bronchial reactivity Frequency of exacerbation QOL Oral and parenteral treatments reserved for those people who require urgent treatment - aerosolised treatment is the most effective mode of delivery to avoid systemic side effects Budesonide Fluticasone Main side effect it oral candidiasis which can be avoided by mouth gargling post treatment